Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
Scientific Reports
|
November 2, 2017
In vivo near-infrared imaging of ErbB2 expressing breast tumors with dual-axes confocal endomicroscopy using a targeted peptide
Zhenghong Gao, Gaoming Li, Xue Li, et al.
Molecular Pharmaceutics
|
April 13, 2019
Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application
Xiaowen Ma, Xiaoyu Kang, Lei He, et al.
Molecular and Cellular Biology
|
July 26, 2002
Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism
Sarah E Ross, Robin L Erickson, Isabelle Gerin, et al.
Elife
|
January 11, 2017
BRAF<sup>V600E</sup> cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis
Naoya Sakamoto, Ying Feng, Carmine Stolfi, et al.
Human Molecular Genetics
|
May 7, 2016
EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression
Coralie Drelon, Annabel Berthon, Mickael Mathieu, et al.
Cell
|
May 3, 2016
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Weimin Wang, Ilona Kryczek, Lubomír Dostál, et al.
Blood
|
August 5, 2018
Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development
Qing Wang, Ran Yan, Nancy Pinnell, et al.
Cancer Research
|
June 5, 2003
Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas
Donald R Schwartz, Rong Wu, Sharon L R Kardia, et al.
Molecular & Cellular Proteomics : MCP
|
March 20, 2003
Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas
Guoan Chen, Hong Wang, Tarek G Gharib, et al.
Cancer Research
|
August 17, 2002
Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas
Donald R Schwartz, Sharon L R Kardia, Kerby A Shedden, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
Scientific Reports
|
November 2, 2017
In vivo near-infrared imaging of ErbB2 expressing breast tumors with dual-axes confocal endomicroscopy using a targeted peptide
Zhenghong Gao, Gaoming Li, Xue Li, et al.
Molecular Pharmaceutics
|
April 13, 2019
Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application
Xiaowen Ma, Xiaoyu Kang, Lei He, et al.
Molecular and Cellular Biology
|
July 26, 2002
Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism
Sarah E Ross, Robin L Erickson, Isabelle Gerin, et al.
Elife
|
January 11, 2017
BRAF<sup>V600E</sup> cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis
Naoya Sakamoto, Ying Feng, Carmine Stolfi, et al.
Human Molecular Genetics
|
May 7, 2016
EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression
Coralie Drelon, Annabel Berthon, Mickael Mathieu, et al.
Cell
|
May 3, 2016
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Weimin Wang, Ilona Kryczek, Lubomír Dostál, et al.
Blood
|
August 5, 2018
Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development
Qing Wang, Ran Yan, Nancy Pinnell, et al.
Cancer Research
|
June 5, 2003
Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas
Donald R Schwartz, Rong Wu, Sharon L R Kardia, et al.
Molecular & Cellular Proteomics : MCP
|
March 20, 2003
Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas
Guoan Chen, Hong Wang, Tarek G Gharib, et al.
Cancer Research
|
August 17, 2002
Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas
Donald R Schwartz, Sharon L R Kardia, Kerby A Shedden, et al.
Page
of 12